SB 162 California Senate · 2017-2018 Regular Session

Cannabis: marketing.

Summary
Existing law, the Medicinal and Adult-Use Cannabis Regulation and Safety Act, which includes the Control, Regulate and Tax Adult Use of Marijuana Act (AUMA) , enacted by the voters at the November 8, 2016, regulates the cultivation, distribution, and use of cannabis for medical purposes and for nonmedical purposes by people 21 years of age and older. Existing law places specified restrictions on the advertising or marketing of cannabis and cannabis products, including prohibiting advertising or marketing cannabis or cannabis products in a manner intended to encourage persons under 21 years of age to consume cannabis or cannabis products. AUMA authorizes legislative amendment of specified sections of AUMA to implement specified substantive provisions of the proposition by a majority vote of each house if the amendments further specified purposes and intent. This bill would specify that advertising or marketing cannabis or cannabis products in a manner intended to encourage persons under 21 years of age to consume cannabis or cannabis products includes all advertising of cannabis or cannabis products through the use of branded merchandise, including, but not limited to, clothing, hats, or other merchandise with the name or logo of the product. This bill states findings and declarations of the Legislature and would declare that its provisions further specified purposes and the intent of the Control, Regulate and Tax Adult Use of Marijuana Act.
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2017
Committee Review
Sep 2017
Senate Passage
May 2017
Assembly Passage
Governor
Introduced Jan 19, 2017 Last action Sep 1, 2017
Floor votes · Senate Jun 1, 2017

How they voted

320
Passed
Total votes 32
Jun 1, 2017
D Democratic22
22 Yea
100% Yea
R Republican10
10 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
27
Key actions
7
Committee
9
Amendments
1
Sep 1, 2017
Lower · Passed
September 1 hearing: Held in committee and under submission.
lower
Jun 27, 2017
Lower · Passed
From committee: Do pass and re-refer to Com. on APPR. (Ayes 12. Noes 0.) (June 27). Re-referred to Com. on APPR.
lower
Jun 15, 2017
Committee
Referred to Com. on B. & P.
lower
Jun 1, 2017
Senate · Passed
Senate Vote: pass (32-0)
senate
May 25, 2017
Upper · Passed
From committee: Do pass. (Ayes 7. Noes 0. Page 1178.) (May 25).
upper
May 3, 2017
Upper · Passed
May 8 hearing postponed by committee.
upper
Apr 19, 2017
Upper · Passed
Read second time and amended. Re-referred to Com. on APPR.
upper
Apr 18, 2017
Upper · Passed
From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 0. Page 726.) (April 17).
upper
Apr 5, 2017
Committee
Re-referred to Com. on B., P. & E.D.
upper
Mar 29, 2017
Committee
Re-referred to Com. on RLS.
upper
Feb 2, 2017
Committee
Referred to Com. on HEALTH.
upper
Jan 19, 2017
Introduced
Introduced. Read first time. To Com. on RLS. for assignment. To print.
upper
0 primary · 1 co-sponsor

Sponsors

No sponsor information available.